CTLA4 and neoplasm: Considering that B68 can induce cellular senescence while reducing the expression of PD‐L1 in tumor cells and that combination therapy with anti‐PD‐L1 and anti‐CTLA4 has better therapeutic effects, we hypothesize that the combination of B68 with anti‐CTLA4 may further enhance B68 antitumor activity.